Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,668,848
+$942,329 QoQ
Shares Held
76,530
+3.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#260
of 1,348 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allen Capital Group, LLC holds $17,687,025 across 8 Drug Manufacturers - General names. NVO ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
218,728 | $5,266,970 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
76,530 | $3,668,848 | |
| 3 | JNJ |
Johnson & Johnson
|
12,012 | $3,050,687 | |
| 4 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,589 | $1,360,686 | |
| 6 | ABBV |
AbbVie Inc.
|
3,915 | $985,170 | |
| 7 | AMGN |
Amgen Inc
|
1,428 | $517,107 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,504 | $316,355 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,668,848 | 76,530 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,726,519 | 74,191 | Shares | Sole | 2026-05-27 | |
| 2025-12-31 | $2,923,768 | 57,464 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,234,179 | 58,284 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||